Valuation: Medpace Holdings, Inc.

Market Cap 18.29B 16.58B 15.33B 13.83B 26.07B 1,725B 26.99B 184B 73.03B 921B 68.64B 67.19B 2,924B P/E 2026 *
35.9x
P/E 2027 * 33.3x
Enterprise Value 17.48B 15.84B 14.65B 13.22B 24.91B 1,648B 25.79B 176B 69.79B 880B 65.6B 64.21B 2,795B EV / Sales 2026 *
6.13x
EV / Sales 2027 * 5.63x
Free-Float
81.14%
Yield 2026 *
-
Yield 2027 * -
1 day-0.44%
1 week+0.13%
Current month+0.30%
1 month+6.05%
3 months+13.04%
6 months+56.01%
Current year+16.43%
1 week 644.77
Extreme 644.7701
679.18
1 month 610.05
Extreme 610.05
693.97
Current year 373
Extreme 373
693.97
1 year 373
Extreme 373
693.97
3 years 250.05
Extreme 250.05
693.97
5 years 126.94
Extreme 126.945
693.97
10 years 21.76
Extreme 21.76
693.97
Manager TitleAgeSince
Chief Executive Officer 69 30/06/1992
Director of Finance/CFO 51 31/07/2021
Chief Tech/Sci/R&D Officer 65 31/08/2017
Director TitleAgeSince
Chairman 69 30/06/1992
Director/Board Member 55 30/06/2016
Director/Board Member 72 30/06/2016
Date Insider Type Main position Quantity % Market Cap. Importance
29/10/26 Sell

Compliance Officer

-1,245 0.0045%
27/10/26 Sell

Chief Operating Officer

-3,940 0.0141%
21/10/26 Exercice

Chief Operating Officer

5,400 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-0.44%+0.13%+10.82%+131.76% 18.29B
-2.69%-0.48%+53.97%+70.99% 66.33B
-0.92%+7.67%+12.64%+92.55% 60.62B
0.00%+0.39%+22.34%+90.83% 55.5B
+0.14%+2.35%+13.86%+106.64% 47.58B
-2.21%-2.47%+20.18%+32.24% 43.69B
-2.30%-10.40%+154.30%+725.54% 37.27B
+2.15%+1.42%+14.58%+54.23% 36.57B
-2.32%-2.24%+76.50%+54.55% 32.22B
+2.62%+5.90%-37.29%+393.72% 26.58B
Average -0.60%+0.06%+34.19%+175.30% 42B
Weighted average by Cap. -0.81%+0.20%+35.52%+154.24%

Financials

2026 *2027 *
Net sales 2.85B 2.58B 2.39B 2.15B 4.06B 269B 4.2B 28.69B 11.38B 144B 10.69B 10.47B 456B 3.02B 2.74B 2.53B 2.28B 4.31B 285B 4.46B 30.42B 12.06B 152B 11.34B 11.1B 483B
Net income 521M 472M 436M 394M 742M 49.08B 768M 5.24B 2.08B 26.22B 1.95B 1.91B 83.22B 554M 502M 464M 419M 789M 52.21B 817M 5.58B 2.21B 27.89B 2.08B 2.03B 88.53B
Net Debt -812M -736M -680M -614M -1.16B -76.53B -1.2B -8.17B -3.24B -40.88B -3.05B -2.98B -130B -1.27B -1.15B -1.07B -962M -1.81B -120B -1.88B -12.81B -5.08B -64.08B -4.77B -4.67B -203B
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,600
Date Price Change Volume
13/11/26 US$653.94 -0.44% 105,452
12/11/26 US$656.84 -1.19% 142,184
11/11/26 US$664.77 +0.03% 134,532
10/11/26 US$664.54 -1.25% 165,203
09/11/26 US$672.93 +3.03% 219,169
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
653.94USD
Average target price
651.31USD
Spread / Average Target
-0.40%
  1. Stock Market
  2. Stocks
  3. MEDP Stock